Founders Financial Securities LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 13.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,034 shares of the exchange traded fund’s stock after selling 4,390 shares during the period. Founders Financial Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $4,578,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of XBI. Axiom Investment Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at about $26,000. Financial Life Planners acquired a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter worth $27,000. Angeles Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth about $28,000. Root Financial Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $31,000. Finally, Morling Financial Advisors LLC acquired a new position in SPDR S&P Biotech ETF in the 2nd quarter worth approximately $36,000.
SPDR S&P Biotech ETF Stock Up 0.2%
Shares of XBI stock opened at $157.79 on Friday. The stock has a market cap of $10.69 billion, a PE ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 52-week low of $106.30 and a 52-week high of $169.89. The business has a 50-day simple moving average of $156.75 and a 200-day simple moving average of $141.41.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
